HOME
WHO IS BDA
BDA DELIVERS
KEY PROJECTS
REFERENCE WORK 
PRINCIPALS & ASSOCIATES
CONTACT US 
Business Development Advisors
Reference Work

Myocor is a clinical-evaluation-stage medical device company that provides innovative, easy-to-use, passive implantable devices to treat heart failure. Since its inception, Myocor has been dedicated to developing and commercializing devices that are intended to improve cardiac performance and efficiency by directly reducing cardiac wall stress in patients diagnosed with heart failure. The company is pioneering the concept of "Shape Change Therapy" in which stress reduction is accomplished by changing the size and shape of the heart's main pumping chamber, the left ventricle. Myocor has finalized the design of its initial therapeutic product, the Myocor Myosplint. Implanted by a cardiac surgeon, the Myosplint does not require placing the patient on cardiopulmonary bypass. It is intended to be a treatment alternative for patients with class III and IV heart failure.

How Sourced: CEO, Management

Our involvement: Preparation for fundraising: business model & plan, presentations, valuation, and investor preparation